The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

BBIO FINANCIAL STATEMENTS

BridgeBio Pharma Inc — balance sheet, income statement and cash flow trends

BBIOBridgeBio Pharma Inc

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
-500 M0500 M202120222023202420252026

Profit Funnel

Q2 2026 · TTM
Revenue677.9 M $Gross Profit649.2 M $ · 96%Operating Income-543.5 M $ · -80%Pre-tax Income-706.2 M $ · -104%Net Income to Owners-696.2 M $ · -103%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue677.9 M $+187.5%
Gross Profit649.2 M $+186.2%
Operating Income-543.5 M $—
EBITDA-573.2 M $—
Net Income to Owners-696.2 M $—

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
-2 B02 B4 B202120222023202420252026

Capital Structure

Q2 2026
Total Assets1.2 B
  • Current Liabilities890.6 M $24%
  • Long-term Liabilities2.8 B $76%

Key Figures

YoY change
Total Assets1.2 B $+12.7%
Total Liabilities3.7 B $+30.2%
Total Equity-2.5 B $—
Cash & ST Investments720.2 M $-4.9%
Total Debt18.3 M $-99.3%
Net Debt18.3 M $-99.1%

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
-600 M-400 M-200 M0202120222023202420252026

Cash Flow Bridge

Q2 2026 · TTM
-400 M-200 M0-434.4 M $Operating-34.1 M $Investing397.4 M $Financing-71.1 M $Net Change

Key Figures

YoY change
Operating Cash Flow-434.4 M $—
Capital Expenditures5.5 M $-52.7%
Free Cash Flow-439.9 M $—
Dividends Paid——

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on BBIO

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 2, 26. This content is for informational purposes only and is not investment advice.